Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice - PubMed (original) (raw)
. 1989 Nov 15;143(10):3230-4.
Affiliations
- PMID: 2809199
Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice
A Fontana et al. J Immunol. 1989.
Abstract
The immunoregulatory effects of human recombinant transforming growth factor (rTGF) beta 1 and human recombinant glioblastoma-derived T cell suppressor factor (rG-TsF)/TGF beta 2 was investigated in mice infected with lymphocytic choriomeningitis virus (LCMV) or vaccinia virus. Starting on the day of infection, i.p. injections of 1 microgram/day or rTGF-beta 1 or rG-TsF/TGF-beta 2 suppressed the generation of virus specific CTL. The effect of TGF-beta on CTL (day 8) was less pronounced when TGF-beta treatment was delayed for 3 days after LCMV infection. rG-TsF/TGF-beta 2 also has an inhibiting effect on CTL-mediated disease in LCMV-infected mice: it prolonged the survival time of mice infected with LCMV and reduced the local swelling reaction after infection into the footpad. These results indicate that rTGF-beta 1 and rG-TsF/TGF-beta 2 influence T cell immune reactivity in vivo.
Similar articles
- CD2-deficient mice generate virus-specific cytotoxic T lymphocytes upon infection with lymphocytic choriomeningitis virus.
Evans CF, Rall GF, Killeen N, Littman D, Oldstone MB. Evans CF, et al. J Immunol. 1993 Dec 1;151(11):6259-64. J Immunol. 1993. PMID: 7902375 - Effects of treatment with IL-2 receptor specific monoclonal antibody in mice. Inhibition of cytotoxic T cell responses but not of T help.
Leist TP, Kohler M, Eppler M, Zinkernagel RM. Leist TP, et al. J Immunol. 1989 Jul 15;143(2):628-32. J Immunol. 1989. PMID: 2544648 Retracted. - Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo.
Kyburz D, Speiser DE, Aebischer T, Hengartner H, Zinkernagel RM. Kyburz D, et al. J Immunol. 1993 Jun 1;150(11):5051-8. J Immunol. 1993. PMID: 7684417 - Expression of TGF-beta 2 in human glioblastoma: a role in resistance to immune rejection?
Fontana A, Bodmer S, Frei K, Malipiero U, Siepl C. Fontana A, et al. Ciba Found Symp. 1991;157:232-8; discussion 238-41. doi: 10.1002/9780470514061.ch15. Ciba Found Symp. 1991. PMID: 1649035 Review. - The transforming growth factor-betas. A new family of immunoregulatory molecules.
Palladino MA, Morris RE, Starnes HF, Levinson AD. Palladino MA, et al. Ann N Y Acad Sci. 1990;593:181-7. doi: 10.1111/j.1749-6632.1990.tb16110.x. Ann N Y Acad Sci. 1990. PMID: 2197960 Review.
Cited by
- TGF-β receptor maintains CD4 T helper cell identity during chronic viral infections.
Lewis GM, Wehrens EJ, Labarta-Bajo L, Streeck H, Zuniga EI. Lewis GM, et al. J Clin Invest. 2016 Oct 3;126(10):3799-3813. doi: 10.1172/JCI87041. Epub 2016 Sep 6. J Clin Invest. 2016. PMID: 27599295 Free PMC article. - Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure.
Odermatt B, Eppler M, Leist TP, Hengartner H, Zinkernagel RM. Odermatt B, et al. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8252-6. doi: 10.1073/pnas.88.18.8252. Proc Natl Acad Sci U S A. 1991. PMID: 1910175 Free PMC article. - Natural selection of tumor variants in the generation of "tumor escape" phenotypes.
Khong HT, Restifo NP. Khong HT, et al. Nat Immunol. 2002 Nov;3(11):999-1005. doi: 10.1038/ni1102-999. Nat Immunol. 2002. PMID: 12407407 Free PMC article. Review. - Factors, including transforming growth factor beta, released in the glioblastoma residual cavity, impair activity of adherent lymphokine-activated killer cells.
Ruffini PA, Rivoltini L, Silvani A, Boiardi A, Parmiani G. Ruffini PA, et al. Cancer Immunol Immunother. 1993 Jun;36(6):409-16. doi: 10.1007/BF01742258. Cancer Immunol Immunother. 1993. PMID: 8500113 Free PMC article. - Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc.
Genestier L, Kasibhatla S, Brunner T, Green DR. Genestier L, et al. J Exp Med. 1999 Jan 18;189(2):231-9. doi: 10.1084/jem.189.2.231. J Exp Med. 1999. PMID: 9892606 Free PMC article.